References
- DiSipio T, Rye S, Newman B, et al. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013;14(6):500–515.
- Fu MR, Axelrod D, Haber J. Breast-cancer-related lymphedema: information, symptoms, and risk-reduction behaviors. J Nurs Scholarship. 2008;40(4):341–348.
- Douglass J, Graves P, Gordon S. Self-care for management of secondary lymphedema: a systematic review. PLoS Negl Trop Dis. 2016;10(6):e0004740–20.
- Campisi C, Davini D, Bellini C, et al. Lymphatic microsurgery for the treatment of lymphedema. Microsurgery. 2006;26(1):65–69.
- Lasinski BB, Thrift KMK, Squire DC, et al. A systematic review of the evidence for complete decongestive therapy in the treatment of lymphedema from 2004 to 2011. Pm & R. 2012;4(8):580–601.
- Mao AS, Mooney DJ. Regenerative medicine: current therapies and future directions. Proc Natl Acad Sci USA. 2015;112(47):14452–14459.
- Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002;13(12):4279–4295.
- Toyserkani NM, Jensen CH, Andersen DC, et al. Treatment of breast cancer-related lymphedema with adipose-derived regenerative cells and fat grafts: a feasibility and safety study. Stem Cells Transl Med. 2017;6(8):1666–1672.
- Takeda K, Sowa Y, Nishino K, et al. Adipose-derived stem cells promote proliferation, migration, and tube formation of lymphatic endothelial cells in vitro by secreting lymphangiogenic factors. Ann Plast Surg. 2015;74(6):728–736.
- Frese L, Dijkman E, Hoerstrup SP. Adipose tissue-derived stem cells in regenerative medicine. Transfus Med Hemother. 2016;43(4):268–274.
- Bourin P, Bunnell BA, Casteilla L, et al. Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy. 2013;15(6):641–648.
- Toyserkani NM, Jensen CH, Andersen DC, et al. Human and autologous adipose-derived stromal cells increase flap survival in rats independently of host immune response. Ann Plast Surg. 2018;80(2):181–187.
- Jørgensen MG, Toyserkani NM, Hansen CR, et al. Quantification of chronic lymphedema in a revised mouse model. Ann Plast Surg. 2018;81(5),:594–603.
- Mekada K, Abe K, Murakami A, et al. Genetic differences among C57BL/6 substrains. Exp Anim. 2009;58(2):141–149.
- Oashi K, Furukawa H, Oyama A, et al. A new model of acquired lymphedema in the mouse hind limb: A preliminary report. Ann Plast Surg. 2012;69(5):565–568.
- Wiinholt A, Jørgensen MG, Bucan A, et al. A revised method for inducing secondary lymphedema in the hindlimb of mice. J Vis Exp. 2019;153.
- Korula P, Varma S, Sunderrao S. Inhibition of wound contraction by point-to-point adherent splintage. Plast Reconstr Surg. 1995;95(4):725–730.
- Modi S, Stanton AWB, Mortimer PS, et al. Clinical assessment of human lymph flow using removal rate constants of interstitial macromolecules: a critical review of lymphoscintigraphy. Lymphat Res Biol. 2007;5(3):183–202.
- Frueh FS, Körbel C, Gassert L, et al. High-resolution 3D volumetry versus conventional measuring techniques for the assessment of experimental lymphedema in the mouse hindlimb. Sci Rep. 2016;6(1):34673.
- Wang JM, Gu Y, Pan CJ, et al. Isolation, culture and identification of human adipose-derived stem cells . Exp Ther Med. 2017;13(3):1039–1043.
- Keating A. Mesenchymal stromal cells: new directions. Cell Stem Cell. 2012;10(6):709–716.
- Dominici M, Blanc KL, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315–317.
- Mildmay-White A, Khan W. Cell surface markers on adipose-derived stem cells: a systematic review. Curr Stem Cell Res Ther. 2017;12(6):484–492.
- Hayashida K, Yoshida S, Yoshimoto H, et al. Adipose-derived stem cells and vascularized lymph node transfers successfully treat mouse hindlimb secondary lymphedema by early reconnection of the lymphatic system and lymphangiogenesis. Plast Reconstr Surg. 2017;139(3):639–651.
- Yoshida S, Hamuy R, Hamada Y, et al. Adipose-derived stem cell transplantation for therapeutic lymphangiogenesis in a mouse secondary lymphedema model. Regen Med. 2015;10(5):549–562.
- Iwasaki D, Yamamoto Y, Murao N, et al. Establishment of an acquired lymphedema model in the mouse hindlimb: technical refinement and molecular characteristics. Plast Reconstr Surg. 2017;139(1):67e–78e.
- Norman SA, Localio AR, Potashnik SL, et al. Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. J Clin Oncol. 2009;27(3):390–397.
- Busch K-H, Aliu A, Walezko N, et al. Medical needling: effect on skin erythema of hypertrophic burn scars. Cureus. 2018;10(9):e3260.
- Allen RJ, Cheng MH. Lymphedema surgery: patient selection and an overview of surgical techniques. J Surg Oncol. 2016;113(8):923–931.